O

Optomed Oyj
OMXH:OPTOMED

Watchlist Manager
Optomed Oyj
OMXH:OPTOMED
Watchlist
Price: 3.81 EUR -0.26% Market Closed
Market Cap: 75m EUR

Optomed Oyj
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Optomed Oyj
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
O
Optomed Oyj
OMXH:OPTOMED
Gross Profit
€11.2m
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
N/A
R
Revenio Group Oyj
OMXH:REG1V
Gross Profit
€78.3m
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
22%
M
Modulight Oyj
OMXH:MODU
Gross Profit
€6m
CAGR 3-Years
-15%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
B
Bioretec Oy
OMXH:BRETEC
Gross Profit
€3.2m
CAGR 3-Years
33%
CAGR 5-Years
21%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Gross Profit
€9.5m
CAGR 3-Years
-2%
CAGR 5-Years
28%
CAGR 10-Years
18%
B
Biohit Oyj
OMXH:BIOBV
Gross Profit
€9.6m
CAGR 3-Years
7%
CAGR 5-Years
17%
CAGR 10-Years
16%
No Stocks Found

Optomed Oyj
Glance View

Market Cap
74.9m EUR
Industry
Health Care

Optomed Oyj engages in the provision of handheld fundus cameras and eye-screening solutions. The company is headquartered in Oulu, Oulun and currently employs 115 full-time employees. The company went IPO on 2019-12-09. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.

OPTOMED Intrinsic Value
4.97 EUR
Undervaluation 23%
Intrinsic Value
Price
O

See Also

What is Optomed Oyj's Gross Profit?
Gross Profit
11.2m EUR

Based on the financial report for Sep 30, 2025, Optomed Oyj's Gross Profit amounts to 11.2m EUR.

What is Optomed Oyj's Gross Profit growth rate?
Gross Profit CAGR 5Y
5%

Over the last year, the Gross Profit growth was 27%. The average annual Gross Profit growth rates for Optomed Oyj have been 9% over the past three years , 5% over the past five years .

Back to Top